Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07Submission of Matters to a Vote of Security Holders.

We held a Special Meeting of Stockholders on September 7, 2017 (the “Special Meeting”). We had 50,228,931 shares of common stock outstanding on July 21, 2017, the record date for Special Meeting. At the Special Meeting, 42,331,096 shares of common stock were present in person or represented by proxy. The following sets forth the final results of the voting for the matter voted upon at the Special Meeting. This matter is described in more detail in the definitive proxy statement we filed with the Securities and Exchange Commission on July 27, 2017.

Proposal 1: To approve an amendment to our certificate of incorporation to effect a reverse stock split of our issued and outstanding common stock at a ratio not less than 1-for-8 and not greater than 1-for-12, with the exact ratio to be set within that range at the discretion of our board of directors before June 20, 2018 without further approval or authorization of our stockholders. The board of directors may alternatively elect to abandon such proposed amendment and not effect the reverse stock split authorized by our stockholders, in its sole discretion.

At the Special Meeting, our stockholders approved the proposal to amend our certificate of incorporation to effect a reverse stock split by the following votes:

2

About Tandem Diabetes Care, Inc. (NASDAQ:TNDM)

Tandem Diabetes Care, Inc. is a medical device company. The Company is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The Company manufactures and sells three insulin pump products, which include t:slim Insulin Delivery System (t:slim), t:flex Insulin Delivery System (t:flex) and t:slim G4 Insulin Delivery System (t:slim G4). Its technology platform features Micro-Delivery Technology, a miniaturized pumping mechanism, which draws insulin from a flexible bag within the pump’s cartridge rather than relying on a syringe and plunger mechanism. It also features a software, which is a vivid color touch screen and a micro- universal serial bus (USB) connection that supports both a rechargeable battery and uploads to t:connect Diabetes Management Application (t:connect), its custom cloud-based data management application that provides display therapy management data from the pump and supported blood glucose meters.